The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis

This 2023 systematic review and meta-analysis evaluated 12 randomized controlled trials involving 651 patients to assess the efficacy and safety of low-intensity extracorporeal shock wave therapy (Li-ESWT), alone or combined with medications, for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Li-ESWT significantly improved NIH-CPSI total, pain, and quality of life scores